Lakeshore Biopharma CO (LSBCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 14,552 | 8,847 | 7,127 | N/A | -3,646 |
| Other Working Capital | 411 | 375 | 69 | N/A | -176 |
| Other Operating Activity | -15,778 | -9,491 | -7,361 | 0 | 3,399 |
| Operating Cash Flow | $-815 | $-269 | $-165 | $N/A | $-423 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 0 | 0 | -200,000 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-200,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 196,000 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 5,498 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $201,498 |
| Beginning Cash Position | 885 | 885 | 885 | N/A | N/A |
| End Cash Position | 70 | 616 | 720 | N/A | 1,075 |
| Net Cash Flow | $-815 | $-269 | $-165 | $N/A | $1,075 |
| Free Cash Flow | |||||
| Operating Cash Flow | -815 | -269 | -165 | N/A | -423 |
| Free Cash Flow | -815 | -269 | -165 | 0 | -423 |